Shuibing Chen
Impact in
- Molecular Biology top 1%
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- Congenital heart defects research
- Renal and related cancers
- Surgery top 1%
- Pancreatic function and diabetes
- Tissue Engineering and Regenerative Medicine
Papers in
-
- Pluripotent Stem Cells Research 23
- CRISPR and Genetic Engineering 10
- Congenital heart defects research 6
- Cancer-related gene regulation 5
- Surgery 23
- Pancreatic function and diabetes 18
- Co-authors
- René Maehr (4 shared papers)Douglas A. Melton (4 shared papers)Kenji Osafune (2 shared papers)Sheng Ding (6 shared papers)Danwei Huangfu (5 shared papers)Wenjun Guo (1 shared paper)Astrid Eijkelenboom (1 shared paper)Whitney E. Muhlestein (1 shared paper)
- Journals
- Cell stem cell (9 papers)Proceedings of the National Academy of Sciences (6 papers)Nature Communications (5 papers)Cell Reports (5 papers)Nature Chemical Biology (3 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Shuibing Chen
76 papers receiving 6.1k citations
Shuibing Chen's Hit Papers
Peers
Comparison fields: 5 of 136
- Molecular Biology 4.3k
- Surgery 1.8k
- Developmental Neuroscience 158
- Aging 55
- Genetics 688
Countries citing papers authored by Shuibing Chen
This map shows the geographic impact of Shuibing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuibing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuibing Chen more than expected).
Fields of papers citing papers by Shuibing Chen
This network shows the impact of papers produced by Shuibing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuibing Chen. The network helps show where Shuibing Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuibing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 Hit paper breakdown → | 2008 | 993 |
| 2 | 2009 | 420 | |
| 3 | 2009 | 368 | |
| 4 | 2006 | 337 | |
| 5 | 2009 | 336 | |
| 6 | 2007 | 303 | |
| 7 | 2017 | 301 | |
| 8 | 2007 | 247 | |
| 9 | 2006 | 241 | |
| 10 | 2016 | 219 | |
| 11 | 2003 | 218 | |
| 12 | 2017 | 202 | |
| 13 | 2017 | 158 | |
| 14 | 2017 | 126 | |
| 15 | 2022 | 104 | |
| 16 | 2016 | 86 | |
| 17 | 2007 | 80 | |
| 18 | 2017 | 79 | |
| 19 | 2016 | 77 | |
| 20 | 2023 | 76 |
About Shuibing Chen
Shuibing Chen is a scholar working on Molecular Biology, Surgery, Genetics, Oncology and Biomedical Engineering, having authored 78 papers that have together received 6.2k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (23 papers), Pancreatic function and diabetes (18 papers), CRISPR and Genetic Engineering (10 papers), 3D Printing in Biomedical Research (9 papers), Congenital heart defects research (6 papers), Genetics and Neurodevelopmental Disorders (6 papers), Cancer-related gene regulation (5 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). The work is most often cited by research in Molecular Biology (4.3k citations), Surgery (1.8k citations), Developmental Neuroscience (158 citations), Aging (55 citations) and Genetics (688 citations). Shuibing Chen has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include René Maehr, Douglas A. Melton, Kenji Osafune, Sheng Ding, Danwei Huangfu, Wenjun Guo, Astrid Eijkelenboom, Whitney E. Muhlestein, Todd Evans and Qisheng Zhang. Their work appears in journals such as Cell stem cell, Proceedings of the National Academy of Sciences, Nature Communications, Cell Reports and Nature Chemical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.